Read + Share
Amedeo Smart
Independent Medical Education
T P. Commentary on "Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (r/mHNSCC)". Oral Oncol 2024;158:107010.PMID: 39191127
Email
LinkedIn
Privacy Policy